Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Chronic Heart Failure

Free Subscription 14.06.2021 2 Am Heart J 2 Am J Cardiol 1 Basic Res Cardiol 1 BMJ 2 Cardiovasc Res 2 Chest 2 Circ Res 7 Circulation 2 Clin Cardiol 7 Eur Heart J 9 Eur J Heart Fail 3 Heart 4 Int J Cardiol 2 J Am Coll Cardiol 7 J Card Fail 3 J Cardiol 1 PLoS Med 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. FUDIM M, Spates T, Sun JL, Kittipibul V, et al
   Early Diuretic Strategies and the Association With In-Hospital and Post-Discharge Outcomes in Acute Heart Failure.
   Am Heart J. 2021 May 27. pii: S0002-8703(21)00140.
   PubMed         Abstract available
   
   
2. NUNEZ-GIL IJ, Olier I, Feltes G, Viana-Llamas MC, et al
   Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.
   Am Heart J. 2021;237:104-115.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

3. ABUGROUN A, Elawad A, Okoh AK, Abdel-Rahman ME, et al
   Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients >/= 60 Years with Implantable Cardioverter Defibrillator.
   Am J Cardiol. 2021 Jun 2. pii: S0002-9149(21)00370.
   PubMed         Abstract available
   
   
4. FARIDI KF, Bhalla N, Atreja N, Venditto J, et al
   New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims).
   Am J Cardiol. 2021 May 27. pii: S0002-9149(21)00373.
   PubMed         Abstract available
   
   

   
   Basic Res Cardiol

5. REMES A, Wagner AH, Schmiedel N, Heckmann M, et al
   AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure.
   Basic Res Cardiol. 2021;116:38.
   PubMed         Abstract available
   
   

   
   BMJ

6. KIM D, Yang PS, You SC, Sung JH, et al
   Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
   BMJ. 2021;373:n991.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

7. NAUMENKO N, Mutikainen M, Holappa L, Ruas JL, et al
   PGC-1alpha deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice.
   Cardiovasc Res. 2021 Jun 4. pii: 6292089. doi: 10.1093.
   PubMed         Abstract available
   
   
8. SANSONETTI M, De Windt LJ
   Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure.
   Cardiovasc Res. 2021 Jun 7. pii: 6294284. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Chest

9. DE MAN FS, Naeije R
   Sex and the Right Ventricle in Heart Failure With Preserved Ejection Fraction.
   Chest. 2021;159:2156-2158.
   PubMed        
   
   
10. SIA YT, Gebhard CE, Denault AY
    Reversal of Acute Right Ventricular Failure Early Post Left Ventricular Assist Device Placement by Intratracheal Milrinone Administration: Case Report.
    Chest. 2021;159:e57-e60.
    PubMed        
    
    

    
    Circ Res

11. HUO JL, Jiao L, An Q, Chen X, et al
    Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure.
    Circ Res. 2021 Jun 3. doi: 10.1161/CIRCRESAHA.120.318149.
    PubMed         Abstract available
    
    
12. GLASENAPP A, Derlin K, Gutberlet M, Hess A, et al
    Molecular Imaging of Inflammation and Fibrosis in Pressure Overload Heart Failure.
    Circ Res. 2021 Jun 2. doi: 10.1161/CIRCRESAHA.120.318539.
    PubMed         Abstract available
    
    

    
    Circulation

13. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    PubMed         Abstract available
    
    
14. MOAYEDI Y, Runeckles K, Posada JD
    Letter by Moayedi et al Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1015-e1016.
    PubMed        
    
    
15. MEHMOOD M
    Letter by Mehmood Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1014.
    PubMed        
    
    
16. JENSEN J, Omar M, Kistorp C, Tuxen C, et al
    Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic).
    Circulation. 2021;143:2208-2210.
    PubMed        
    
    
17. BIRKS EJ, Rame JE, Cunningham C, Drakos SG, et al
    Response by Birks et al to Letters Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1017-e1018.
    PubMed        
    
    
18. FELKER GM, Butler J, Januzzi JL Jr, Desai AS, et al
    Probabilistic Readjudication of Heart Failure Hospitalization Events in the PARAGON-HF Study.
    Circulation. 2021;143:2316-2318.
    PubMed        
    
    
19. 
    Correction to: Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.
    Circulation. 2021;143:e1027.
    PubMed        
    
    

    
    Clin Cardiol

20. VAN WOERDEN G, van Veldhuisen DJ, Gorter TM, van Empel VPM, et al
    Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction.
    Clin Cardiol. 2021 Jun 4. doi: 10.1002/clc.23644.
    PubMed         Abstract available
    
    
21. SEKMA A, Bel Haj Ali K, Jeddi C, Ben Brahim N, et al
    Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
    Clin Cardiol. 2021 Jun 2. doi: 10.1002/clc.23615.
    PubMed         Abstract available
    
    

    
    Eur Heart J

22. WITHAAR C, Meems LMG, de Boer RA
    Fighting HFpEF in women: taking aim at belly fat.
    Eur Heart J. 2021;42:1606-1608.
    PubMed        
    
    
23. RAJAGOPALAN S, Brook RD, Al-Kindi S
    Air pollution and flooding in the lungs: modern insights into ancient problems.
    Eur Heart J. 2021;42:1592-1594.
    PubMed        
    
    
24. PORCHER R, Desguerre I, Amthor H, Chabrol B, et al
    Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy-analysis of registry data.
    Eur Heart J. 2021;42:1976-1984.
    PubMed         Abstract available
    
    
25. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed         Abstract available
    
    
26. ZANNAD F, Cotter G, Alonso Garcia A, George S, et al
    What can heart failure trialists learn from oncology trialists?
    Eur Heart J. 2021 Jun 2. pii: 6291019. doi: 10.1093.
    PubMed         Abstract available
    
    
27. JANKOWSKA EA, Kirwan BA, Kosiborod M, Butler J, et al
    The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
    Eur Heart J. 2021 Jun 3. pii: 6291468. doi: 10.1093.
    PubMed         Abstract available
    
    
28. NICHOLLS M
    Recognition for heart failure breakthrough.
    Eur Heart J. 2021 Jun 11. pii: 6296965. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Heart Fail

29. STOLFO D, Savarese G
    Association Between Heart Failure and Cancer: Is Gender the Answer?
    Eur J Heart Fail. 2021 Jun 11. doi: 10.1002/ejhf.2261.
    PubMed        
    
    
30. BHATT AS, Vaduganathan M, Claggett BL, Liu J, et al
    Effect of Sacubitril/Valsartan versus Enalapril on Changes in Heart Failure Therapies Over Time: The PARADIGM-HF Trial.
    Eur J Heart Fail. 2021 Jun 7. doi: 10.1002/ejhf.2259.
    PubMed         Abstract available
    
    
31. PACKER M, Januzzi JL Jr, Ferreira JP, Anker SD, et al
    Concentration-Dependent Clinical and Prognostic Importance of High-Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: the EMPEROR-Reduced Trial.
    Eur J Heart Fail. 2021 May 30. doi: 10.1002/ejhf.2256.
    PubMed         Abstract available
    
    
32. BUTLER J, Yang M, Sawhney B, Chakladar S, et al
    Treatment Patterns and Clinical Outcomes Among Patients <65 Years with a Worsening Heart Failure Event.
    Eur J Heart Fail. 2021 May 30. doi: 10.1002/ejhf.2252.
    PubMed         Abstract available
    
    
33. SORIMACHI H, Burkhoff D, Verbrugge FH, Omote K, et al
    Obesity, Venous Capacitance, and Venous Compliance in Heart Failure with Preserved Ejection Fraction.
    Eur J Heart Fail. 2021 May 30. doi: 10.1002/ejhf.2254.
    PubMed         Abstract available
    
    
34. GRAHAM FJ, Masini G, Pellicori P, Cleland JGF, et al
    Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure.
    Eur J Heart Fail. 2021 May 28. doi: 10.1002/ejhf.2251.
    PubMed         Abstract available
    
    
35. FADINI GP, Avogaro A
    A simple way to spotlight hidden heart failure in type 2 diabetes?
    Eur J Heart Fail. 2021 May 28. doi: 10.1002/ejhf.2258.
    PubMed        
    
    
36. TKACZYSZYN M, Comin-Colet J, Voors AA, van Veldhuisen DJ, et al
    Iron deficiency contributes to the resistance to endogenous erythropoietin in anaemic heart failure patients.
    Eur J Heart Fail. 2021 May 29. doi: 10.1002/ejhf.2253.
    PubMed         Abstract available
    
    
37. SOLOMON SD, de Boer RA, DeMets D, Hernandez AF, et al
    Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial.
    Eur J Heart Fail. 2021 May 29. doi: 10.1002/ejhf.2249.
    PubMed         Abstract available
    
    

    
    Heart

38. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed         Abstract available
    
    
39. DESAI RJ, Patorno E, Vaduganathan M, Mahesri M, et al
    Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319405. doi: 10.1136/heartjnl-2021-319405.
    PubMed         Abstract available
    
    
40. GRIFFIN J, Cheng R
    Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319545. doi: 10.1136/heartjnl-2021-319545.
    PubMed        
    
    

    
    Int J Cardiol

41. RAJDEV K, Lahan S, Wichman T
    Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
    PubMed         Abstract available
    
    
42. VALERIANOVA A, Malik J, Janeckova J, Kovarova L, et al
    Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.
    Int J Cardiol. 2021;334:148-153.
    PubMed         Abstract available
    
    
43. LIU L, Lima JAC, Post WS, Szklo M, et al
    Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.
    Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00908.
    PubMed         Abstract available
    
    
44. EMOTO T, Hayashi T, Tabata T, Yamashita T, et al
    Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
    Int J Cardiol. 2021 Jun 5. pii: S0167-5273(21)00962.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

45. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
    Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;77:2796-2803.
    PubMed         Abstract available
    
    
46. CONDORELLI G, Ferrante G
    MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
    J Am Coll Cardiol. 2021;77:2936-2938.
    PubMed        
    
    

    
    J Card Fail

47. ALBERT NM
    Heart Failure is Everywhere: Insuring Diversity in Care Across Gender, Age, Race and Ethnicities.
    J Card Fail. 2021;27:722-723.
    PubMed        
    
    
48. GERMAN CA, Brubaker PH, Nelson MB, Fanning J, et al
    Relationships Between Objectively Measured Physical Activity, Exercise Capacity, and Quality of Life in Older Patients With Obese Heart Failure and Preserved Ejection Fraction.
    J Card Fail. 2021;27:635-641.
    PubMed         Abstract available
    
    
49. BLUMER V, Correa A, Youmans QR
    The Early Career and Trainee Spotlight at the Journal of Cardiac Failure.
    J Card Fail. 2021;27:716-717.
    PubMed        
    
    
50. FERRARO RA, Ogunmoroti O, Zhao D, Ndumele CE, et al
    Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    J Card Fail. 2021 May 26. pii: S1071-9164(21)00194.
    PubMed         Abstract available
    
    
51. AMAR M, Lam SW, Faulkenberg K, Perez A, et al
    Captopril versus hydralazine-isosorbide dinitrate vasodilator protocols in acute decompensated heart failure patients transitioning from sodium nitroprusside.
    J Card Fail. 2021 May 26. pii: S1071-9164(21)00197.
    PubMed         Abstract available
    
    
52. OBATA H, Izumi T, Yamashita M, Mitsuma W, et al
    Characteristics of Elderly Patients with Heart Failure and Impact on Activities of Daily Living. A Registry Report from Super-Aged Society: ADL in elderly heart failure patients.
    J Card Fail. 2021 May 27. pii: S1071-9164(21)00198.
    PubMed         Abstract available
    
    
53. GELFMAN LP, Mather H, McKendrick K, Wong AY, et al
    Non-Concordance between Patient and Clinician Estimates of Prognosis in Advanced Heart Failure.
    J Card Fail. 2021;27:700-705.
    PubMed         Abstract available
    
    

    
    J Cardiol

54. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed         Abstract available
    
    
55. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed         Abstract available
    
    
56. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed         Abstract available
    
    

    
    PLoS Med

57. AHN HJ, Lee SR, Choi EK, Han KD, et al
    Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study.
    PLoS Med. 2021;18:e1003659.
    PubMed         Abstract available
    
    

    
    PLoS One

58. TAKAHASHI S, Tanno K, Yonekura Y, Ohsawa M, et al
    Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group.
    PLoS One. 2021;16:e0253017.
    PubMed         Abstract available
    
    
59. MAHESRI M, Chin K, Kumar A, Barve A, et al
    External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
    PLoS One. 2021;16:e0252903.
    PubMed         Abstract available
    
    
60. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Cardiac index predicts long-term outcomes in patients with heart failure.
    PLoS One. 2021;16:e0252833.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: